2-(4-Bromophenyl)-5-phenyl-1,3,4-oxadiazole,
21510-43-0,
CNLVYZSUMYQALH-UHFFFAOYSA-N,
MFCD00050997,
1,3,4-Oxadiazole, 2-(4-bromophenyl)-5-phenyl-,
5-(4-bromophenyl)-2-phenyl-1,3,4-oxadiazole,
NSC89572,
AC1L3GSG,
ACMC-1CQ4F,
AC1Q24QI,
Cambridge id 5570574,
SCHEMBL861223,
CTK4E7008,
ZINC85624,
DTXSID70175850,
AC1Q2768,
KS-000018UH,
EINECS 244-413-6,
4811AH,
NSC-89572,
SBB059558,
AKOS000597273,
MCULE-4994879769,
SC-54389,
TC-171707,
A4737,
BB 0238711,
CS-0063185,
FT-0608597,
ST50102445,
K-6150,
AB00089714-01,
1,3,4-Oxadiazole,2-(4-bromophenyl)-5-phenyl-,
SR-01000396390,
2-(4-Bromo-phenyl)-5-phenyl-[1,3,4]oxadiazo le,
J-014119,
SR-01000396390-1,
2-(4-Bromophenyl)-5-phenyl-1,3,4-oxadiazole, 96%,
I14-47658,
F1018-0437,
3-Bromofuran,
C14H9BrN2O,
CID88931,
AR-1C7572,
2-(4-Bromophenyl)-5-phenyl-1,3,4-oxadiazole, 97% - 1G 1g,
22037-28-1,